Targeted inhibition of human collagenase-3 (MMP-13) expression inhibits squamous cell carcinoma growth in vivo

Oncogene

Volumn 23, Issue 30, 2004, Pages 5111-5123

  Ala Aho, Risto ^a   Ahonen, Matti ^a   George, Sarah J ^b   Heikkilä, Jari ^c   Grénman, Reidar ^d   Kallajoki, Markku ^d   Kähäri, Veli Matti ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b BRISTOL ROYAL INFIRMARY   (United Kingdom)

^c ÅBO AKADEMI UNIVERSITY   (Finland)

^d TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Collagenase; Invasion; Ribozyme; Squamous cell carcinoma

Indexed keywords

ADENOVIRUS VECTOR; ANTINEOPLASTIC AGENT; COLLAGENASE 3; COLLAGENASE INHIBITOR; MATRIGEL; RIBOZYME; COLLAGEN; COLLAGENASE; GELATINASE; LAMININ; MESSENGER RNA; MMP13 PROTEIN, HUMAN; MMP13 PROTEIN, MOUSE; PROTEOGLYCAN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CELL COUNT; CELL PROLIFERATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENCY; EMBRYO; ENZYME INHIBITION; ENZYME SYNTHESIS; GENE TARGETING; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; SKIN METASTASIS; SQUAMOUS CELL CARCINOMA; XENOGRAFT; ADENOVIRUS; ANIMAL; CANCER TRANSPLANTATION; CELL CULTURE; CELL DIVISION; CELL SURVIVAL; CYTOLOGY; DRUG ANTAGONISM; DRUG COMBINATION; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HEAD AND NECK TUMOR; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MALE; METABOLISM; METASTASIS; MOUSE; MOUSE MUTANT; PATHOLOGY; TIME;

ADENOVIRIDAE;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; CELL SURVIVAL; COLLAGEN; COLLAGENASES; DRUG COMBINATIONS; GELATINASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; LAMININ; MALE; MATRIX METALLOPROTEINASE 13; MICE; MICE, SCID; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; PROTEOGLYCANS; RNA, MESSENGER; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 3142701642     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207678     Document Type: Article

References (51)

1. Ahonen M, Ala-aho R, Baker AH, George SJ, Grénman R, Saarialho-Kere U and Kähäri V-M. (2002). Mol. Ther., 5, 705-715.
2. Ahonen M, Poukkula M, Baker AH, Kashiwagi M, Nagase H, Eriksson JE and Kähäri V-M. (2003). Oncogene, 22, 2121-2134.
3. Airola K, Johansson N, Kariniemi A-L, Kähäri V-M and Saarialho-Kere U. (1997). J. Invest. Dermatol., 109, 225-231.
4. Airola K, Karonen T, Vaalamo M, Lehti K, Lohi J, Kariniemi AL, Keski-Oja J and Saarialho-Kere UK. (1999). Br. J. Cancer, 80, 733-743.
5. Ala-aho R, Grénman R, Seth P and Kähäri V-M. (2002a). Oncogene, 21, 1187-1195.
6. Ala-aho R, Johansson N, Baker AH and Kähäri V-M. (2002b). Int. J. Cancer, 97, 283-289.
7. Ala-aho R, Johansson N, Grénman R, Fusenig NE, López-Otín C and Kähäri V-M. (2000). Oncogene, 19, 248-257.
8. Ashworth JL, Murphy G, Rock MJ, Sherratt MJ, Shapiro SD, Shuttleworth CA and Kielty CM. (1999). Biochem. J., 340, 171-181.
9. Boström PJ, Ravanti L, Reunanen N, Aaltonen V, Söderström K-O, Kähäri V-M and Laato M. (2000). Int. J. Cancer, 88, 417-423.
10. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A and Fusenig NE. (1988). J. Cell. Biol., 106, 761-771.
11. Boukamp P, Stanbridge EJ, Foo DY, Cerutti PA and Fusenig NE. (1990). Cancer Res., 50, 2840-2847.
12. Cazorla M, Hernandez L, Nadal A, Balbín M, López JM, Vizoso F, Fernandez PL, Iwata K, Cardesa A, López-Otín C and Campo E. (1998). J. Pathol., 186, 144-150.
13. Etoh T, Inoue H, Yoshikawa Y, Barnard GF, Kitano S and Mori M. (2000). Gut, 47, 50-56.
14. Fosang AJ, Last K, Knäuper V, Murphy G and Neame PJ. (1996). FEBS Lett., 380, 17-20.
15. Freije JM, Diéz-Itza I, Balbín M, Sánchez LM, Blasco R, Tolivia J and López-Otín C. (1994). J. Biol. Chem., 269, 16766-16773.
16. George SJ, Lloyd CT, Angelini GD, Newby AC and Baker AH. (2000). Circulation, 101, 296-304.
17. Hernandez YJ, Wang J, Kearns WG, Loiler S, Poirier A and Flotte TR. (1999). J. Virol., 73, 8549-8558.
18. Hua J and Muschel RJ. (1996). Cancer Res., 56, 5279-5284.
19. Jarvis TC, Bouhana KS, Lesch ME, Brown SA, Parry TJ, Schrier DJ, Hunt III SW, Pavco PA and Flory CM. (2000). J. Immunol., 165, 493-498.
20. Johansson N, Airola K, Grénman R, Kariniemi A-L, Saarialho-Kere U and Kähäri V-M. (1997a). Am. J. Pathol., 151, 499-508.
21. Johansson N, Saarialho-Kere U, Airola K, Herva R, Nissinen L, Westermarck J, Vuorio E, Heino J and Kähäri V-M. (1997b). Dev. Dyn., 208, 387-395.
22. Johansson N, Vaalamo M, Grénman S, Hietanen S, Klemi P, Saarialho-Kere U and Kähäri V-M. (1999). Am. J. Pathol., 154, 469-480.
23. Johansson N, Westermarck J, Leppä S, Häkkinen L, Koivisto L, López-Otín C, Peltonen J, Heino J and Kähäri V-M. (1997c). Cell Growth Differ., 8, 243-250.
24. Knäuper V, Cowell S, Smith B, López-Otín C, O'Shea M, Morris H, Zardi L and Murphy G. (1997a). J. Biol. Chem., 272, 7608-7616.
25. Knäuper V, López-Otín C, Smith B, Knight G and Murphy G. (1996). J. Biol. Chem., 271, 1544-1550.
26. Knäuper V, Smith B, López-Otín C and Murphy G. (1997b). Eur. J. Biochem., 248, 369-373.
27. Lewin AS and Hauswirth WW. (2001). Trends Mol. Med., 7, 221-228.
28. Lindy O, Konttinen YT, Sorsa T, Ding Y, Santavirta S, Ceponis A and López-Otín C. (1997). Arthritis Rheum., 40, 1391-1399.
29. Lu Y, Zhang Y and Steiner MS. (1998). DNA Cell Biol., 17, 643-645.
30. Mao D, Lee JK, VanVickle SJ and Thompson RW. (1999). Biochem. Biophys. Res. Commun., 261, 904-910.
31. McQuibban GA, Butler GS, Gong JH, Bendall L, Power C, Clark-Lewis I and Overall CM. (2001). J. Biol. Chem., 276, 43503-43508.
32. McQuibban GA, Gong JH, Tam EM, McCulloch CA, Clark-Lewis I and Overall CM. (2000). Science, 289, 1202-1206.
33. Murphy G and Knäuper V. (1997). Matrix Biol., 15, 511-518.
34. Nelson AR, Fingleton B, Rothenberg ML and Matrisian LM. (2000). J. Clin. Oncol., 18, 1135-1149.
35. Nielsen BS, Rank F, López JM, Balbin M, Vizoso F, Lund LR, Danø K and López-Otín C. (2001). Cancer Res., 61, 7091-7100.
36. Nikkola J, Vihinen P, Vlaykova T, Hahka-Kemppinen M, Kähäri V-M and Pyrhönen S. (2001). Melanoma Res., 11, 157-166.
37. Overall CM and López-Otín C. (2002). Nat. Rev. Cancer, 2, 657-672.
38. Pavco PA, Bouhana KS, Gallegos AM, Agrawal A, Blanchard KS, Grimm SL, Jensen KL, Andrews LE, Wincott FE, Pitot PA, Tressler RJ, Cushman C, Reynolds MA and Parry TJ. (2000). Clin. Cancer Res., 6, 2094-2103.
39. Ravanti L, Häkkinen L, Larjava H, Saarialho-Kere U, Foschi M, Han J and Kähäri V-M. (1999b). J. Biol. Chem., 274, 37292-37300.
40. Ravanti L, Heino J, López-Otín C and Kähäri VM. (1999a). J. Biol. Chem., 274, 2446-2455.
41. Ravanti L, Toriseva M, Penttinen R, Crombleholme T, Foschi M, Han J and Kähäri V-M. (2001). FASEB J., 15, 1098-1100.
42. Reboul P, Pelletier J-P, Tardif G, Cloutier J-M and Martel-Pelletier J. (1996). J. Clin. Invest., 97, 2011-2019.
43. Santiago FS and Khachigian LM. (2001). J. Mol. Med., 79, 695-706.
44. Sukhova GK, Schönbeck U, Rabkin E, Schoen FJ, Poole AR, Billinghurst RC and Libby P. (1999). Circulation, 99, 2503-2509.
45. Uitto V-J, Airola K, Vaalamo M, Johansson N, Putnins EE, Firth JD, Salonen J, López-Otín C, Saarialho-Kere U and Kähäri V-M. (1998). Am. J. Pathol., 152, 1489-1499.
46. Uría JA, Balbín M, López JM, Alvarez J, Vizoso F, Takigawa M and López-Otín C. (1998). Am. J. Pathol., 153, 91-101.
47. Usman N and Blatt LM. (2000). J. Clin. Invest., 106, 1197-1202.
48. Vaalamo M, Karjalainen-Lindsberg M-L, Puolakkainen P, Kere J and Saarialho-Kere U. (1998). Am. J. Pathol., 152, 1005-1014.
49. Vaalamo M, Mattila L, Johansson N, Kariniemi A-L, Karjalainen-Lindsberg M-L, Kähäri V-M and Saarialho-Kere U. (1997). J. Invest. Dermatol., 109, 96-101.
50. Vihinen P and Kähäri V-M. (2002). Int. J. Cancer, 99, 157-166.
51. Wilkinson GW and Akrigg A. (1992). Nucleic Acids Res., 20, 2233-2239.